After fighting hard to win their regular-season finale against the Indianapolis Colts, the Houston Texans hold the No. 2 overall pick in the 2023 NFL Draft. Many criticized the Texans' decision to effectively give away the No. 1 overall pick, since they are in the market for a new quarterback and no longer have the pick of the litter. While we all assume general manager Nick Caserio will draft a signal-caller at No. 2 overall, is it possible he won't?
According to NBC Sports, one league personnel man believes the Texans could pass on taking a quarterback at No. 2 overall, and instead use their second first-rounder, No. 12 overall, to facilitate a trade up the board. Peter King points out that Caserio can be conservative, and if he doesn't absolutely love a quarterback at No. 2 overall, he may not force it.
"It's a stretch, but I could see Nick taking Anderson, then using his second [first-round pick] and trading back up to get his quarterback," the league personnel man told King.
If Houston does not draft a quarterback at No. 2 overall, the pick would likely be Alabama pass-rusher Will Anderson Jr. -- who is seen as the No. 1 overall prospect in this class. It's also worth mentioning that the Texans passing on a quarterback at No. 2 overall would be a major win for the Arizona Cardinals at No. 3 overall. The Cardinals already have their franchise quarterback in Kyler Murray, so they could fetch a pretty penny for that selection.
Pick Six Newsletter
Crafted By The Best NFL Experts
Get the day's big stories + fun stuff you love like mock drafts, picks and power rankings.
Thanks for signing up!
Keep an eye on your inbox.
There was an error processing your subscription.
Anything is possible, but Houston taking a quarterback at No. 2 overall is still expected. Over at Caesars Sportsbook, Alabama quarterback Bryce Young is the heavy favorite to be selected at No. 2 overall (-250). He's followed by quarterbacks C.J. Stroud (+250), Will Levis (+1200) and Anthony Richardson (+1600). Anderson is +2000 to be picked second overall.